Table 6.
Heparin | Anti-Xa activity (U/mg) | Anti-IIa activity (u/mg) | Anti-Xa/anti-IIa (ratio) |
---|---|---|---|
UFH | 201 | 201 | 1 |
LMWH-II | 163 ± 4 | 59 ± 6 | 2.7 |
Enoxaparin | 170 ± 5 | 47 ± 4 | 3.6 |
Enoxaparin* | 184 ± 2 | 45 ± 3 | 4.1 |
Nadroparin* | 178 ± 9 | 67 ± 4 | 2.7 |
Dalteparin* | 172 ± 6 | 93 ± 9 | 2.4 |
Tinzaparin* | 181 ± 7 | 45 ± 3 | 3.9 |
Data based on the results from Achour O. et al.21